Alterations in Fatty Acid Utilization and an Impaired Antioxidant Defense Mechanism Are Early Events in Podocyte Injury A Proteomic Analysis

被引:37
作者
Mayrhofer, Corina [1 ,2 ]
Krieger, Sigurd [1 ]
Huttary, Nicole [1 ]
Chang, Martina Wei-Fen [3 ]
Grillari, Johannes [3 ,4 ]
Allmaier, Guenter [2 ]
Kerjaschki, Dontscho [1 ]
机构
[1] Med Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria
[2] Vienna Univ Technol, Inst Chem Technol & Analyt, A-1040 Vienna, Austria
[3] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Vienna, Austria
[4] BMT Res Vienna, Vienna, Austria
基金
奥地利科学基金会;
关键词
PUROMYCIN AMINONUCLEOSIDE NEPHROSIS; GLOMERULAR CAPILLARY WALL; LOW-DENSITY-LIPOPROTEIN; UNCOUPLING PROTEIN-3; LIPID-PEROXIDATION; IN-VITRO; ELECTRON MICROSCOPE; BASEMENT-MEMBRANE; BETA-OXIDATION; CD36;
D O I
10.2353/ajpath.2009.080654
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Ultrastructural alterations of podocytes are closely associated with loss of glomerular filtration function. In the present study, we explored changes at the proteome level that paralleled the disturbances of podocyte architecture in the early stages of puromycin aminonucleoside (PA) nephrosis in vivo. Using two-dimensional fluorescence difference gel electrophoresis and vacuum matrix-assisted laser desorption/ionization mass spectrometry combined with postsource decay fragment ion analysis and high-energy collision-induced dissociation tandem mass spectrometry, 23 differentially expressed protein spots, corresponding to 16 glomerular proteins that are involved in various cellular functions, were unambiguously identified, and a subset was corroborated by Western blot analysis. The majority of these proteins were primarily related to fatty acid metabolism and redox regulation. Key enzymes of the mitochondrial beta-oxidation pathway and antioxidant enzymes were consistently down-regulated in PA nephrosis. These changes were paralleled by increased expression levels of CD36. PA treatment of murine podocytes in culture resembled these specific protein changes in vitro. In this cell system, the modulatory effects of albumin-bound fatty acids on the expression levels of Mn-superoxide dismutase in response to PA were demonstrated as well. Taken together, these results indicate that a disrupted fatty acid metabolism in concert with an impaired antioxidant defense mechanism in podocytes may play a role in the early stages of PA-induced lesions in podocytes. (Am J Pathol 2009, 174:1191-1202; DOI: 10.2353/ajpath.2009.080654)
引用
收藏
页码:1191 / 1202
页数:12
相关论文
共 74 条
[31]   SUPEROXIDE RADICAL AND SUPEROXIDE DISMUTASES [J].
FRIDOVICH, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :97-112
[32]   CHARACTERIZATION OF CATIONIC ALBUMIN IN MINIMAL CHANGE NEPHROPATHY [J].
GHIGGERI, GM ;
GINEVRI, F ;
CANDIANO, G ;
OLEGGINI, R ;
PERFUMO, F ;
QUEIROLO, C ;
GUSMANO, R .
KIDNEY INTERNATIONAL, 1987, 32 (04) :547-553
[33]  
GREENWALT DE, 1992, BLOOD, V80, P1105
[34]   Formation of one or more intrachain disulphide bonds is required for the intracellular processing and transport of CD36 [J].
Gruarin, P ;
Sitia, R ;
Alessio, M .
BIOCHEMICAL JOURNAL, 1997, 328 :635-642
[35]  
Gwinner W, 1997, J AM SOC NEPHROL, V8, P1722
[36]  
HARKIN JC, 1960, AM J PATHOL, V36, P303
[37]   Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: An hypothesis [J].
Himms-Hagen, J ;
Harper, ME .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 226 (02) :78-84
[38]   The effect of high-fat feeding on intramuscular lipid and lipid peroxidation levels in UCP3-ablated mice [J].
Hoeks, J ;
Hesselink, MKC ;
Sluiter, W ;
Schaart, G ;
Willems, J ;
Morrisson, A ;
Clapham, JC ;
Saris, WHM ;
Schrauwen, P .
FEBS LETTERS, 2006, 580 (05) :1371-1375
[39]   Altered gene expression and functions of mitochondria in human nephrotic syndrome [J].
Holthöfer, H ;
Kretzler, M ;
Haltia, A ;
Solin, ML ;
Taanman, JW ;
Schägger, H ;
Kriz, W ;
Kerjaschki, D ;
Schlöndorff, D .
FASEB JOURNAL, 1999, 13 (03) :523-532
[40]   Role of CD36 in membrane transport of long-chain fatty acids [J].
Ibrahimi, A ;
Abumrad, NA .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (02) :139-145